Company profile
BioCorRx Inc.
OTC: BICX · Healthcare · Medical - Care Facilities
#890 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
44DFH 30DQ 57GM 62SS 39
v0.1 · 65/100 weight · provisional
↑ revenue growth (YoY), disclosure history · ↓ growth stability, workforce scale
Methodology →Revenue TTM
$786.6k
Rev growth YoY (TTM)
+151.2%
Net income (FY)
-$3.4M
Employees
3
as of 2026-08-23
Market cap
$5.9M
as of 2026-08-23
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$797.2k$797.2k2025
Net income-$3.4M-$3.4M2025
Operating income-$4.8M-$4.8M2025
Total assets$2.1M$2.1M2025
Liabilities$13.7M$13.7M2025
Equity-$11.2M-$11.2M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is BioCorRx Inc.’s revenue?
BioCorRx Inc. booked $797.2k in FY2025 revenue, growing 10301% year over year — faster than 99% of Healthcare companies we track, at a -431.5% net margin.
Peers · Healthcare
Hyperion DeFi, Inc.35DHelix BioMedix, Inc.56CImageneBio Inc48DSeres Therapeutics, Inc.52DHerborium Group, Inc.36DRising Biosciences, Inc.——Neighbors
Orange →Key facts
CEOLourdes Felix
SectorHealthcare
IndustryMedical - Care Facilities
HeadquartersAnaheim, CA
ExchangeOTC: BICX
Employees3
IPO date2010-08-31
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.